Merck KGaA (MRK) - Total Liabilities
Based on the latest financial reports, Merck KGaA (MRK) has total liabilities worth €23.44 Billion EUR (≈ $27.40 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Merck KGaA annual equity growth to track the company's year-over-year net asset growth rate.
Merck KGaA - Total Liabilities Trend (2002–2025)
This chart illustrates how Merck KGaA's total liabilities have evolved over time, based on quarterly financial data. See Merck KGaA free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Merck KGaA Competitors by Total Liabilities
The table below lists competitors of Merck KGaA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Omnicom Group Inc
NYSE:OMC
|
USA | $39.89 Billion |
|
Jiangsu Hengli Hydraulic Co Ltd
SHG:601100
|
China | CN¥3.90 Billion |
|
Dow Inc
NYSE:DOW
|
USA | $43.02 Billion |
|
Telefónica S.A
F:TNE2
|
Germany | €74.21 Billion |
|
AXIA Energia SA
NYSE:AXIA-PC
|
USA | $158.72 Billion |
|
Church & Dwight Company Inc
NYSE:CHD
|
USA | $4.82 Billion |
|
Telefonica SA ADR
NYSE:TEF
|
USA | $71.22 Billion |
|
Lundin Mining Corporation
TO:LUN
|
Canada | CA$2.75 Billion |
Liability Composition Analysis (2002–2025)
This chart breaks down Merck KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Merck KGaA market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.46 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.82 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.45 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Merck KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Merck KGaA (2002–2025)
The table below shows the annual total liabilities of Merck KGaA from 2002 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €23.44 Billion ≈ $27.40 Billion |
+8.62% |
| 2024-12-31 | €21.58 Billion ≈ $25.23 Billion |
-0.74% |
| 2023-12-31 | €21.74 Billion ≈ $25.42 Billion |
-3.47% |
| 2022-12-31 | €22.52 Billion ≈ $26.33 Billion |
-5.95% |
| 2021-12-31 | €23.95 Billion ≈ $28.00 Billion |
-3.36% |
| 2020-12-31 | €24.78 Billion ≈ $28.97 Billion |
-4.32% |
| 2019-12-31 | €25.90 Billion ≈ $30.28 Billion |
+31.76% |
| 2018-12-31 | €19.66 Billion ≈ $22.98 Billion |
-8.81% |
| 2017-12-31 | €21.55 Billion ≈ $25.20 Billion |
-10.93% |
| 2016-12-31 | €24.20 Billion ≈ $28.29 Billion |
-3.78% |
| 2015-12-31 | €25.15 Billion ≈ $29.41 Billion |
+77.01% |
| 2014-12-31 | €14.21 Billion ≈ $16.61 Billion |
+45.74% |
| 2013-12-31 | €9.75 Billion ≈ $11.40 Billion |
-13.17% |
| 2012-12-31 | €11.23 Billion ≈ $13.13 Billion |
-3.42% |
| 2011-12-31 | €11.63 Billion ≈ $13.59 Billion |
-3.24% |
| 2010-12-31 | €12.02 Billion ≈ $14.05 Billion |
+66.91% |
| 2009-12-31 | €7.20 Billion ≈ $8.42 Billion |
+19.50% |
| 2008-12-31 | €6.02 Billion ≈ $7.04 Billion |
-3.38% |
| 2007-12-31 | €6.23 Billion ≈ $7.29 Billion |
+45.16% |
| 2006-12-31 | €4.30 Billion ≈ $5.02 Billion |
+8.69% |
| 2005-12-31 | €3.95 Billion ≈ $4.62 Billion |
+39.77% |
| 2004-12-31 | €2.83 Billion ≈ $3.31 Billion |
-38.79% |
| 2003-12-31 | €4.62 Billion ≈ $5.40 Billion |
-15.36% |
| 2002-12-31 | €5.46 Billion ≈ $6.38 Billion |
-- |
About Merck KGaA
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for re… Read more